Adar Poonawalla’s most important product was never the vaccine. It was the price.
Whenever historians look back at India’s fight against COVID-19 through the lens of its vaccination drive, two words will likely stand out: rate and price. By June 2021, the Serum Institute of India, under CEO Adar Poonawalla, with the ability to export 280 million+ doses of its vaccine, Covishield, to 70 countries in that single…